ERBB2 and neoplasm: Despite the high coverage depth generated, the low tumor cell content and overall level of gene amplification in a sample can reduce the sensitivity of this approach, as illustrated by a false negative Her2-amplified sample, which had low in situ hybridization ratio (2.8) and 50% tumor cell content.